3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development (AAPS Advances in the Pharmaceutical Sciences Series, 44, Band 44) - Hardcover

 
9783031460142: 3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development (AAPS Advances in the Pharmaceutical Sciences Series, 44, Band 44)
Hardcover
ISBN 10: 3031460146 ISBN 13: 9783031460142
Verlag: Springer, 2023

Inhaltsangabe

This inclusive text describes 3D Printing for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques.  Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine.

Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided.  Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.  

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.

Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing.  Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas. 

Von der hinteren Coverseite

This book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers.  The particular focus is on hot melt extrusion and the extruded filaments suitable for optimizing the 3D printing in drug development. 3D Printing Polymeric Excipients, Technology, and Drug Formulation Development covers regulatory aspects as well as the manufacturing aspects.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
Springer
Erscheinungsdatum
2023
Sprache
Englisch
ISBN 10 
3031460146
ISBN 13 
9783031460142
Einband
Gebundene Ausgabe
Auflage
1
Anzahl der Seiten
299
Herausgeber
Repka Michael A., Langley Nigel
Kontakt zum Hersteller
Springer Nature Customer Service Center GmbH
ProductSafety@springernature.com

Europaplatz 3
Heidelberg
69115
Deutschland

Weitere beliebte Ausgaben desselben Titels

9783031460173: 3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development (AAPS Advances in the Pharmaceutical Sciences Series, Band 44)

Vorgestellte Ausgabe

ISBN 10:  3031460170 ISBN 13:  9783031460173
Verlag: Springer, 2024
Softcover